Special NoticePosted Dec 22, 2025·Original deadline passed (Oct 16). See latest amendment for current deadline.

6550--NEW - Cepheid Reagents Contract

Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
325413
Value
Not stated
Solicitation
36C25726Q0029
Set-aside
None stated
PSC
6550
Place
Not stated
Contact
Susan Flores (Susan.flores2@va.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C25726Q0029 in this department, oldest first.

Early notice
  • Oct 2, 2025
    Special Notice
    Open
  • Dec 22, 2025 · this notice
    Special Notice
Solicitation
None posted
Award
  • Dec 29, 2025
    Award Notice
    CEPHEID SUNNYVALE 94089 · $6.3M
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Special Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a Firm-Fixed priced, IDIQ contract with five ordering periods to Cepheid. The GeneXpert system can only be used with the GeneXpert cartridge. Item # Description/Part Number* Qty XPRS4PLEX-10 KIT,IVD,XPRESS,COV-2/FLU/RSV PLUS,10TEST Xpert Xpress CoV-2/Flu/RSV plus Detection and differentiation of Flu A, Flu B, RSV and SARS- CoV-2, which all present with similar symptoms 680 XPRS-COV2-10 KIT,10 TEST,XPRESS COVID PLU… (show all)

S,US-IVD Xpert Xpress CoV-2 plus Qualitative detection of nucleic acid from SARS-CoV-2 with three gene targets for the detection of SARS-CoV-2, providing target redundancy that mitigates impact of genetic mutations. 385 This order is for an IDIQ contract for CEPHEID XPRS-COV2-10 KIT,10 TEST,XPRESS COVID PLUS,US-IVD and XPRS4PLEX-10 KIT,IVD,XPRESS,COV-2/FLU/RSV PLUS,10 TEST supplies. 1. The vendor shall provide testing educational materials and procedures of testing supplies at no additional cost. 2. The vendor shall deliver all testing supplies at no additional Government cost. 3. The vendor shall deliver testing supplies that are according to manufacturer specification, CLIA, FDA and CAP requirements. 4. In the event that requested supplies are on back-order, vendor is to inform COR as to the estimated time of availability. 5. The items on this contract are not on a delivery schedule. The customer will call vendor with order request for items needed. The South Texas VA Health Care System (STVHCS) and Pathology and Laboratory Medicine Service (P&LMS) located in San Antonio, Texas, requests a Vendor to provide XPRS4PLEX-10 KIT,IVD,XPRESS,COV-2/FLU/RSV PLUS,10 TEST and supplies. The vendor must be able to sequester reagent lots so that the lot numbers will be the same throughout the contract year. The vendor must provide confirmation of order same day as order request is received.The vendor must provide tracking information and provide an estimated delivery time. The vendor must be able to provide next-day delivery of the following reagents as needed: The sole source justification submitted by the requesting activity states that Cepheid is the only vendor able to provide this service. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 7 days from the publication of this notice, a contract/order will be issued to Cepheid without any further notice. The proposed contract actions are for services, which the government intends to negotiate with only one source. The anticipated statutory authorities permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The proposed sole source procurement will be made by a pricing agreement with Cepheid

Who won similar work

12 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6550 and NAICS 325413.

Single-winner award sizes (12): middle half $392K to $1.4M, median $857K; range $107K to $2.0M.

WinnerAwardsValueLast
CEPHEID SUNNYVALE 940892$2.1MApr 2, 2026
BECTON, DICKINSON AND COMPANY · $BDX · $22.5B2$2.1MApr 27, 2026
ROCHE DIAGNOSTICS CORPORATION2$1.5MAug 28, 2026
GOVERNMENT SCIENTIFIC SOURCE INC2$1.5MJun 2, 2026
BIOMERIEUX INC1$2.0MAug 6, 2025
VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC1$1.0MAug 4, 2025
BECKMAN COULTER, INC1$406KMar 19, 2025
HOLOGIC SALES AND SERVICE, LLC1$350KOct 2, 2025

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Investor context
  • $BDX reported $22.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 12 past awards, $857K, is under 0.1% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (6 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • $25K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 4 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.